Medications
AstraZeneca says in talks with Acerta Pharma
British phamaceuticals giant AstraZeneca revealed Monday that it was in discussions over a deal with cancer drug maker Acerta Pharma.
Dec 14, 2015
0
1
Page 5 - News tagged with biotechnology company
Medications
Bristol-Myers could spend $2.2B in deal with Dutch biotech (Update)
Bristol-Myers Squibb, one of the world's largest drugmakers, will team up with a Dutch biotechnology company whose first approved drug could cost more than $1 million.
Apr 6, 2015
0
6
Medications
Gilead's Harvoni accepted in Canadian health plan
Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.
Mar 24, 2015
0
3
Other
Irish biotech firm Elan rejects new Royalty bid
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Medications
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
May 13, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Oncology & Cancer
Biological markers increase clinical trial success rate of new breast cancer drugs
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
Oncology & Cancer
Georgetown University Medical Center licenses 'theranostic' for development
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Jan 24, 2012
0
0
